Bowhead Specialty vs Greenlight Capital Re
BOW and GLRE side by side, both in fire, marine, and casualty insurance. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BOW and GLRE compare
Bowhead Specialty is the larger company, worth 2.1 times as much as Greenlight Capital Re ($1.1B against $537M).
On earnings, Greenlight Capital Re is cheaper: it trades at 9.7× trailing earnings, against 18.4× for Bowhead Specialty.
Bowhead Specialty grew revenue faster over the last twelve months (25.0% versus 3.7% for Greenlight Capital Re).
Bowhead Specialty keeps more of each dollar of sales as profit, with a net margin of 10.1% compared with 8.6% at Greenlight Capital Re.
Greenlight Capital Re scores higher on the StockData Score (11 against 6 for Bowhead Specialty), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BOW | GLRE |
|---|---|---|
| Size and price | ||
| Market cap | $1.1B | $537M |
| Share price | $34.13 | $16.45 |
| Change, 1 year | 27.5% | 26.2% |
| Change, 5 years | – | 132% |
| Beta (5Y) | 0.33 | 0.39 |
| Employees | 296 | 84 |
| StockData Score | ||
| Total score | 6 | 11 (better) |
| Valuation score | 1 | 6 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 2 | 3 (better) |
| Health score | 0 | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 18.4× | 9.7× (better) |
| P/S | 1.8× | 0.8× (better) |
| P/B | 2.4× | 0.8× (better) |
| EV/EBITDA | 11.1× | – |
| P/FCF | 3.4× | – |
| PEG | 0.37 | 0.22 (better) |
| FCF yield | 29.2% | – |
| Fair value | $26.38 | $21.66 |
| Margin of safety | −29.4% | 24.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 25.0% (better) | 3.7% |
| Revenue growth, 5Y average | – | 8.6% |
| Net income growth (TTM) | 25.7% | – |
| EPS growth (TTM) | 26.7% | – |
| EPS growth, 5Y average | – | 81.6% |
| Profitability | ||
| Net margin | 10.1% (better) | 8.6% |
| FCF margin | 53.5% | – |
| Return on equity | 14.1% (better) | 8.7% |
| Financial health | ||
| Altman Z-score | 0.61 | 0.64 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 5.6% |
| Shareholder yield | 0.00% | 5.6% (better) |
| Ownership | ||
| Held by institutions | 92.7% | 51.2% |
| Held by insiders | 76.6% | 24.8% |
| Insider net buying, 12 months | – | −$2.3M |
| Short interest, % of float | 19.6% | 2.8% |
Go deeper
- BOW stock overview
- BOW income statement
- BOW valuation and score
- GLRE stock overview
- GLRE income statement
- GLRE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.